Genomic technologies and the diagnosis of 46, XY differences of sex development.

Nef S, Stévant I, Greenfield A. Characterizing the bipotential mammalian gonad. Curr Top Dev Biol. 2019;134:167‐194. doi:10.1016/bs.ctdb.2019.01.002

Sinclair AH, Berta P, Palmer MS, et al. A gene from the human sex‐determining region encodes a protein with homology to a conserved DNA‐binding motif. Nature. 1990;346(6281):240‐244. doi:10.1038/346240a0

Arboleda VA, Sandberg DE, Vilain E. DSDs: genetics, underlying pathologies and psychosexual differentiation. Nat Rev Endocrinol. 2014;10(10):603‐615. doi:10.1038/nrendo.2014.130

Baxter RM, Arboleda VA, Lee H, et al. Exome sequencing for the diagnosis of 46, XY disorders of sex development. J Clin Endocrinol Metab. 2015;100(2):E333‐E344. doi:10.1210/jc.2014‐2605

Eggers S, Sadedin S, van den Bergen JA, et al. Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol. 2016;17(1):243. doi:10.1186/s13059‐016‐1105‐y

Délot EC, Papp JC, Sandberg DE, Vilain E. Genetics of disorders of sex development: the DSD‐TRN experience. Endocrinol Metab Clin North Am. 2017;46(2):519‐537. doi:10.1016/j.ecl.2017.01.015

Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554‐563. doi:10.1136/adc.2006.098319

Finney EL, Finlayson C, Rosoklija I, et al. Prenatal detection and evaluation of differences of sex development. J Pediatr Urol. 2020;16(1):89‐96. doi:10.1016/j.jpurol.2019.11.005

Blackless M, Charuvastra A, Derryck A, Fausto‐Sterling A, Lauzanne K, Lee E. How sexually dimorphic are we? Review and synthesis. Am J Hum Biol. 2000;12(2):151‐166. doi:10.1002/(SICI)1520‐6300(200003/04)12:2<151::AID‐AJHB1>3.0.CO;2‐F

Eggers S, Sinclair A. Mammalian sex determination—insights from humans and mice. Chromosome Res. 2012;20(1):215‐238. doi:10.1007/s10577‐012‐9274‐3

Bouty A, Ayers KL, Pask A, Heloury Y, Sinclair AH. The genetic and environmental factors underlying hypospadias. Sex Dev. 2015;9(5):239‐259. doi:10.1159/000441988

Cools M, Nordenström A, Robeva R, et al. Caring for individuals with a difference of sex development (DSD): a consensus statement. Nat Rev Endocrinol. 2018;14(7):415‐429. doi:10.1038/s41574‐018‐0010‐8

Yang Y, Workman S, Wilson M. The molecular pathways underlying early gonadal development. J Mol Endocrinol. 2018;62:R47–R64. doi:10.1530/jme‐17‐0314

Sekido R. SRY: a transcriptional activator of mammalian testis determination. Int J Biochem Cell Biol. 2010;42(3):417‐420. doi:10.1016/j.biocel.2009.12.005

Sekido R, Bar I, Narváez V, Penny G, Lovell‐Badge R. SOX9 is up‐regulated by the transient expression of SRY specifically in Sertoli cell precursors. Dev Biol. 2004;274(2):271‐279. doi:10.1016/j.ydbio.2004.07.011

Eggers S, Ohnesorg T, Sinclair A. Genetic regulation of mammalian gonad development. Nat Rev Endocrinol. 2014;10(11):673‐683. doi:10.1038/nrendo.2014.163

Behringer RR, Finegold MJ, Cate RL. Müllerian‐inhibiting substance function during mammalian sexual development. Cell. 1994;79(3):415‐425. doi:10.1016/0092‐8674(94)90251‐8

Yao HH, Whoriskey W, Capel B. Desert hedgehog/patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis. Genes Dev. 2002;16(11):1433‐1440. doi:10.1101/gad.981202

Habert R, Lejeune H, Saez JM. Origin, differentiation and regulation of fetal and adult Leydig cells. Mol Cell Endocrinol. 2001;179(1‐2):47‐74. doi:10.1016/s0303‐7207(01)00461‐0

McElreavey K, Bashamboo A. Monogenic forms of DSD: an update. Horm Res Paediatr. 2023;96(2):144‐168. doi:10.1159/000521381

Lefebvre V. Roles and regulation of SOX transcription factors in skeletogenesis. Curr Top Dev Biol. 2019;133:171‐193. doi:10.1016/bs.ctdb.2019.01.007

Conte FA, Grumbach MM, Kaplan SL. A diphasic pattern of gonadotropin secretion in patients with the syndrome of gonadal dysgenesis. J Clin Endocrinol Metab. 1975;40(4):670‐674. doi:10.1210/jcem‐40‐4‐670

Fleming A, Vilain E. The endless quest for sex determination genes. Clin Genet. 2005;67(1):15‐25. doi:10.1111/j.1399‐0004.2004.00376.x

Kia F, Sarafoglou K, Mooganayakanakote Siddappa A, Roberts KD. Partial gonadal dysgenesis associated with a pathogenic variant of PBX1 transcription factor. BMJ Case Rep. 2019;12(7):e227986. doi:10.1136/bcr‐2018‐227986

Fabbri HC, Ribeiro de Andrade JG, Maciel‐Guerra AT, Guerra‐Junior G, de Mello MP. NR5A1 loss‐of‐function mutations lead to 46, XY partial gonadal dysgenesis phenotype: report of three novel mutations. Sex Dev. 2016;10(4):191. doi:10.1159/000448013

Buonocore F, Clifford‐Mobley O, King TFJ, et al. Next‐generation sequencing reveals novel genetic variants (SRY, DMRT1, NR5A1, DHH, DHX37) in adults with 46, XY DSD. J Endocr Soc. 2019;3(12):2341. doi:10.1210/js.2019‐00306

Baz‐Redón N, Soler‐Colomer L, Fernández‐Cancio M, et al. Novel variant in HHAT as a cause of different sex development with partial gonadal dysgenesis associated with microcephaly, eye defects, and distal phalangeal hypoplasia of both thumbs: case report. Front Endocrinol (Lausanne). 2022;13:957969. doi:10.3389/fendo.2022.957969

Barbaro M, Oscarson M, Schoumans J, Staaf J, Ivarsson SA, Wedell A. Isolated 46, XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab. 2007;92(8):3305‐3313. doi:10.1210/jc.2007‐0505

Nishi MY, Faria Júnior JAD, Krepischi ACV, et al. A small supernumerary Xp marker chromosome including genes NR0B1 and MAGEB causing partial gonadal dysgenesis and gonadoblastoma. Sex Dev. 2022;16(1):55‐63. doi:10.1159/000517085

Francese‐Santos AP, Meinel JA, Piveta CSC, et al. A novel look at dosage‐sensitive sex locus Xp21.2 in a case of 46, XY partial gonadal dysgenesis without NR0B1 duplication. Int J Mol Sci. 2023;24(1):494.

Ito M, Yu R, Jameson JL. DAX‐1 inhibits SF‐1‐mediated transactivation via a carboxy‐terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol. 1997;17(3):1476‐1483. doi:10.1128/MCB.17.3.1476

Nistal M, Paniagua R, González‐Peramato P, Reyes‐Múgica M. Perspectives in pediatric pathology, chapter 7. Ovotesticular DSD (true hermaphroditism). Pediatr Dev Pathol. 2015;18(5):345‐352. doi:10.2350/14‐04‐1466‐pb.1

Smith A, Robin N. NR5A1 pathogenic variant identified in non‐syndromic 46, XY ovotesticular disorder of sexual development. Arch Pediatr. 2019;4:162.

Ledig S, Hiort O, Wünsch L, Wieacker P. Partial deletion of DMRT1 causes 46, XY ovotesticular disorder of sexual development. Eur J Endocrinol. 2012;167(1):119‐124. doi:10.1530/eje‐12‐0136

Maier EM, Leitner C, Löhrs U, Kuhnle U. True hermaphroditism in an XY individual due to a familial point mutation of the SRY gene. J Pediatr Endocrinol Metab. 2003;16(4):575‐580. doi:10.1515/jpem.2003.16.4.575

Cameron FJ, Hageman RM, Cooke‐Yarborough C, et al. A novel germ line mutation in SOX9 causes familial campomelic dysplasia and sex reversal. Hum Mol Genet. 1996;5(10):1625‐1630. doi:10.1093/hmg/5.10.1625

Hegarty PK, Mushtaq I, Sebire NJ. Natural history of testicular regression syndrome and consequences for clinical management. J Pediatr Urol. 2007;3(3):206‐208. doi:10.1016/j.jpurol.2006.08.007

Heksch RA, Matheson MA, Tishelman AC, et al. Testicular regression syndrome: practice variation in diagnosis and management. Endocr Pract. 2019;25(8):779‐786. doi:10.4158/EP‐2019‐0032

Philibert P, Zenaty D, Lin L, et al. Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod. 2007;22(12):3255‐3261. doi:10.1093/humrep/dem278

Elazizi L, Elazime Z, Lahmamssi FZ, Salhi H, Elouahabi H. Testicular regression syndrome: two case studies. Cureus. 2023;15(2):e34771. doi:10.7759/cureus.34771

de Oliveira FR, Mazzola TN, de Mello MP, et al. DHX37 and NR5A1 variants identified in patients with 46, XY partial gonadal dysgenesis. Life (2075‐1729). 2023;13(5):1093. doi:10.3390/life13051093

Mendonca BB, Costa EM, Belgorosky A, Rivarola MA, Domenice S. 46, XY DSD due to impaired androgen production. Best Pract Res Clin Endocrinol Metab. 2010;24(2):243‐262. doi:10.1016/j.beem.2009.11.003

Galdiero M, Vitale P, Simeoli C, et al. The 17β‐hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18‐year patient and review of the literature. Minerva Endocrinol. 2013;38(1):113‐122.

Krishnappa B, Arya S, Lila AR, et al. 17β hydroxysteroid dehydrogenase 3 deficiency in 46, XY disorders of sex development: our experience and a gender role‐focused systematic review. Clin Endocrinol (Oxf). 2022;97(1):43‐51. doi:10.1111/cen.14694

Neocleous V, Sismani C, Shammas C, et al. Duplication of exons 3–10 of the HSD17B3 gene: a novel type of genetic defect underlying 17β‐HSD‐3 deficiency. Gene. 2012;499(2):250‐255. doi:10.1016/j.gene.2012.03.031

Ben Rhouma B, Belguith N, Mnif MF, et al. A novel nonsense mutation in HSD17B3 gene in a Tunisian patient with sexual ambiguity. J Sex Med. 2013;10(10):2586‐2589. doi:10.1111/j.1743‐6109.2012.02763.x

George MM, New MI, Ten S, Sultan C, Bhangoo A. The clinical and molecular heterogeneity of 17βHSD‐3 enzyme deficiency. Horm Res Paediatr. 2010;74(4):229‐240. doi:10.1159/000318004

Massanyi EZ, Gearhart JP, Kolp LA, Migeon CJ. Novel mutation among two sisters with 17β hydroxysteroid dehydrogenase type 3 deficiency. Urology. 2013;81(5):1069‐1071. doi:10.1016/j.urology.2012.12.024

Hassan HA, Mazen I, Gad YZ, Ali OS, Mekkawy M, Essawi ML. A novel nonsense mutation in exon 1 of HSD17B3 gene in an Egyptian 46, XY adult female presenting with primary amenorrhea. Sex Dev. 2013;7(6):277‐281. doi:10.1159/000351822

Askew EB, Gampe RT, Stanley TB, Faggart JL, Wilson EM. Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone*. J Biol Chem. 2007;282(35):25801‐25816. doi:10.1074/jbc.M703268200

Robevska G, Hanna C, van den Bergen J, et al. Genetic variants in SRD5A2 in a spectrum of DSD patients from Australian clinics highlight importance of genetic testing alongside typical first‐line investigations. Sex Dev. 2023;17(1):8‐15. doi:10.1159/000527754

Batista RL, Mendonca BB. The molecular basis of 5α‐reductase type 2 deficiency. Sex Dev. 2022;16(2‐3):171‐183. doi:10.1159/000525119

Kumar G, Barboza‐Meca JJ. 5 Alpha Reductase Deficiency. In: StatPearls. StatPearls Publishing LLC; 2022:4151‐4160.

Boehmer AL, Brinkmann O, Brüggenwirth H, et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab. 2001;86(9):4151‐41560. doi:10.1210/jcem.86.9.7825

The Human Gene Mutation Database. Androgen Receptor Mutation. Accessed August 19, 2023. https://www.hgmd.cf.ac.uk/ac/gene.php?gene=AR

Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J. Androgen insensitivity syndrome. Lancet North Am Ed. 2012;380(9851):1419‐1428. doi:10.1016/S0140‐6736(12)60071‐3

Doehnert U, Bertelloni S, Werner R, Dati E, Hiort O. Characteristic features of reproductive hormone profiles in late adolescent and adult females with complete androgen insensitivity syndrome. Sex Dev. 2015;9(2):69‐74. doi:10.1159/000371464

Kar B, Sivamani S, Kundavi S, Varma TR. Complete androgen insensitivity syndrome in three generations of Indian pedigree. J Obstet Gynaecol India. 2016;66(Suppl 1):358‐362. doi:10.1007/s13224‐015‐0736‐3

Alanazi AB, Aldhowayan A, Almuhanna MM, Alghamdi AM. Persistent Mullerian duct syndrome (PMDS): case report and review of literature. Urol Case Rep. 2022;42:102031. doi:10.1016/j.eucr.2022.102031

Mullen RD, Behringer RR. Molecular genetics of Müllerian duct formation, regression and differentiation. Sex Dev. 2014;8(5):281‐296. doi:10.1159/000364935

Baskin LS. Hypospadias and urethral development. J Urol. 2000;163(3):951‐956.

Sijstermans K, Hack WW, Meijer RW, van der Voort‐Doedens LM. The frequency of undescended testis from birth to adulthood: a review. Int J Androl. 2008;31(1):1‐11. doi:10.1111/j.1365‐2605.2007.00770.x

Kurz D. Current management of undescended testes. Curr Treat Options Pediatr. 2016;2(1):43‐51. doi:10.1007/s40746‐016‐0039‐7

Ayers K, Kumar R, Robevska G, et al. Familial bilateral cryptorchidism is caused by recessive variants in RXFP2. J Med Genet. 2019;56(11):727‐733. doi:10.1136/jmedgenet‐2019‐106203

Ruan L, Gu M, Geng H, et al. Achieving an optimal pregnancy outcome through the combined utilization of micro‐TESE and ICSI in cryptorchidism associated with a non‐canonical splicing variant in RXFP2. J Assist Reprod Genet. 2024;41(5):1307‐1317. doi:10.1007/s10815‐024‐03070‐4

Dicke AK, Albrethsen J, Hoare BL, et al. Bi‐allelic variants in INSL3 and RXFP2 cause bilateral cryptorchidism and male infertility. Hum Reprod. 2023;38(7):1412‐1423. doi:10.1093/humrep/dead105

Flück CE, Audí L, Fernández‐Cancio M, et al. Broad phenotypes of disorders/differences of sex development in MAMLD1 patients through oligogenic disease. Front Genet. 2019;10:746. doi:10.3389/fgene.2019.00746

Li L, Gao F, Fan L, Su C, Liang X, Gong C. Disorders of sex development in individuals harbouring MAMLD1 variants: WES and interactome evidence of oligogenic inheritance. Front Endocrinol (Lausanne). 2020;11:582516. doi:10.3389/fendo.2020.582516

Camats N, Fernández‐Cancio M, Audí L, et al. Human MAMLD1 gene variations seem not sufficient to explain a 46, XY DSD phenotype. PLoS ONE. 2015;10(11):e0142831. doi:10.1371/journal.pone.0142831

Kalfa N, Cassorla F, Audran F, et al. Polymorphisms of MAMLD1 gene in hypospadias. J Pediatr Urol. 2011;7(6):585‐591. doi:10.1016/j.jpurol.2011.09.005

Chen Y, Thai HT, Lundin J, et al. Mutational study of the MAMLD1‐gene in hypospadias. Eur J Med Genet. 2010;53(3):122‐126. doi:10.1016/j.ejmg.2010.03.005

Fukami M, Wada Y, Okada M, et al. Mastermind‐like domain‐containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence. J Biol Chem. 2008;283(9):5525‐5532. doi:10.1074/jbc.M703289200

Miyado M, Nakamura M, Miyado K, et al. Mamld1 deficiency significantly reduces mRNA expression levels of multiple genes expressed in mouse fetal Leydig cells but permits normal genital and reproductive development. Endocrinology. 2012;153(12):6033‐6040. doi:10.1210/en.2012‐1324

Camats N, Flück CE, Audí L. Oligogenic origin of differences of sex development in humans. Int J Mol Sci. 2020;21(5):1809. doi:10.3390/ijms21051809

Audi L, Ahmed SF, Krone N, et al. GENETICS IN ENDOCRINOLOGY: approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’. Eur J Endocrinol. 2018;179(4):R197‐R206. doi:10.1530/eje‐18‐0256

Ahmed SF, Achermann J, Alderson J, et al. Society for endocrinology UK Guidance on the initial evaluation of a suspected difference or disorder of sex development (Revised 2021). Clin Endocrinol (Oxf). 2021;95(6):818‐840. doi:10.1111/cen.14528

Xu Y, Wang Y, Li N, et al. New insights from unbiased panel and whole‐exome sequencing in a large Chinese cohort with disorders of sex development. Eur J Endocrinol. 2019;181(3):311‐323. doi:10.1530/EJE‐19‐0111

Laan M, Kasak L, Timinskas K, et al. NR5A1 c.991‐1G >C splice‐site variant causes familial 46, XY partial gonadal dysgenesis with incomplete penetrance. Clin Endocrinol (Oxf). 2021;94(4):656‐666. doi:10.1111/cen.14381

Ilaslan E, Calvel P, Nowak D, et al. A case of two sisters suffering from 46, XY gonadal dysgenesis and carrying a mutation of a novel candidate sex‐determining gene STARD8 on the X chromosome. Sex Dev. 2018;12(4):191‐195. doi:10.1159/000489692

Martinez de LaPiscina I, de Mingo C, Riedl S, et al. GATA4 variants in individuals with a 46, XY disorder of sex development (DSD) may or may not be associated with cardiac defects depending on second hits in other DSD genes. Front Med. 2018;9:142. doi:10.3389/fendo.2018.00142

Rothacker KM, Ayers KL, Tang D, et al. A novel, homozygous mutation in desert hedgehog (DHH) in a 46, XY patient with dysgenetic testes presenting with primary amenorrhoea: a case report. Int J Pediatr Endocrinol. 2018;2018:2. doi:10.1186/s13633‐018‐0056‐3

Chen C, Xu X, Kong L, et al. Novel homozygous nonsense mutations in LHCGR lead to empty follicle syndrome and 46, XY disorder of sex development. Hum Reprod. 2018;33(7):1364‐1369. doi:10.1093/humrep/dey215

Sullivan CA, Hoffman JD, Safer JD. 17‐β‐hydroxysteroid dehydrogenase type 3 deficiency: identifying a rare cause of 46, XY female phenotype in adulthood. J Clin Transl Endocrino: Case Rep. 2018;7:5‐7. doi:10.1016/j.jecr.2017.10.002

Sarathi V, Reddy R, Atluri S, Shivaprasad C. A challenging case of primary amenorrhoea. BMJ Case Rep. 2018;2018:bcr‐2018‐225447. doi:10.1136/bcr‐2018‐225447

Unal E, Yıldırım R, Tekin S, Demir V, Onay H, Haspolat YK. A novel mutation of AMHR2 in two siblings with persistent Müllerian duct syndrome. J Clin Res Pediatr Endocrinol. 2018;10(4):387‐390. doi:10.4274/jcrpe.0013

Abd Wahab AV, Lim LM, Mohamed Tarmizi MH. Ovotesticular disorders of sex development: improvement in spermatogonia after removal of ovary and Müllerian structures. J Pediatr Adolesc Gynecol. 2019;32(1):74‐77. doi:10.1016/j.jpag.2018.09.006

Nagy O, Kárteszi J, Hartwig M, et al. The importance of the multiplex ligation‐dependent probe amplification in the identification of a novel two‐exon deletion of the NR5A1 gene in a patient with 46, XY differences of sex development. Mol Biol Rep. 2019;46(5):5595‐5601. doi:10.1007/s11033‐019‐04980‐8

Farnaaz K, Kyriakie S, Ashajyothi Mooganayakanakote S, Kari DR. Partial gonadal dysgenesis associated with a pathogenic variant of <em>PBX1</em> transcription factor. BMJ Case Rep. 2019;12(7):e227986. doi:10.1136/bcr‐2018‐227986

Guran T, Yesil G, Turan S, et al. PPP2R3C gene variants cause syndromic 46, XY gonadal dysgenesis and impaired spermatogenesis in humans. Eur J Endocrinol. 2019;180(5):291‐309. doi:10.1530/eje‐19‐0067

García‐Acero M, Molina M, Moreno O, et al. Gene dosage of DAX‐1, determining in sexual differentiation: duplication of DAX‐1 in two sisters with gonadal dysgenesis. Mol Biol Rep. 2019;46(3):2971‐2978. doi:10.1007/s11033‐019‐04758‐y

Fernández‐Cancio M, Viswanath N, Puzhankara R, et al. A novel homozygous AMRH2 gene mutation in a patient with persistent Müllerian duct syndrome. Sex Dev. 2019;13(2):87‐91. doi:10.1159/000499324

Schteingart HF, Picard J‐Y, Valeri C, et al. A mutation inactivating the distal SF1 binding site on the human anti‐Müllerian hormone promoter causes persistent Müllerian duct syndrome. Hum Mol Genet. 2019;28(19):3211‐3218. doi:10.1093/hmg/ddz147

Wagner‐Mahler K, Kurzenne J‐Y, Gastaud F, et al. Is interstitial 8p23 microdeletion responsible of 46, XY gonadal dysgenesis? Mol Genet Genomic Med. 2019;7(3):e558. doi:10.1002/mgg3.558

Al Shamsi A, Al Hassani N, Hamchou M, Almazrouei R, Mhanni A. A novel missense heterozygous mutation in MAP3K1 gene causes 46, XY disorder of sex development: case report and literature review. Mol Genet Genomic Med. 2020;8(11):e1514. doi:10.1002/mgg3.1514

Kunitomo M, Khokhar A, Kresge C, Edobor‐Osula F, Pletcher BA. 46, XY DSD and limb abnormalities in a female with a de novo LHX9 missense mutation. Am J Med Genet A. 2020;182(12):2887‐2890. doi:10.1002/ajmg.a.61860

Xu ZY, Zhang JX, Liu Y, Geng Q, Xie JS, Li XJ. [46, XY DSD induced by a novel mutation c.458T>C (p.Leu153Pro) of the LHCGR gene: a case report and review of the literature]. Zhonghua Nan Ke Xue. 2020;26(12):1105‐1111.

Hassan HA, Essawi ML, Mekkawy MK, Mazen I. Novel mutations of the LHCGR gene in two families with 46, XY DSD causing Leydig cell hypoplasia I. Hormones. 2020;19(4):573‐579. doi:10.1007/s42000‐020‐00226‐6

Hughes JJ, Alkhunaizi E, Kruszka P, et al. Loss‐of‐function variants in PPP1R12A: from isolated sex reversal to holoprosencephaly spectrum and urogenital malformations. Am Hum Genet. 2020;106(1):121‐128. doi:10.1016/j.ajhg.2019.12.004

Altunoglu U, Börklü E, Shukla A, et al. Expanding the spectrum of syndromic PPP2R3C‐related XY gonadal dysgenesis to XX gonadal dysgenesis. Clin Genet. 2022;101(2):221‐232. doi:10.1111/cge.14086

Laochareonsuk W, Jaruratanasirikul S, Maneechay W, Sangkhathat S. Early diagnosis of CYP17A1 compound heterozygous mutations in a 46, XY child with disorders of sexual development. Urol Sci. 2021;32(1):40.

Acar S, Nalbantoğlu Ö, Gürsoy S, et al. Identification of two AMH gene variants in two unrelated patients with persistent Müllerian duct syndrome: one novel variant. Gynecol Endocrinol. 2021;37(5):476‐479. doi:10.1080/09513590.2021.1908253

Akramov NR, Shavaliev RF, Osipova IV. New mutation in WT1 gene in a boy with an incomplete form of Denys‐Drash syndrome: a CARE‐compliant case report. Medicine (Baltimore). 2021;100(19):e25864. doi:10.1097/md.0000000000025864

Edwards A, Passoni NM, Collins R, Vidi S, Gattineni J, Baker LA. Papers presented at the fall 2020 pediatric urologic oncology work group of the societies of pediatric urology meetingneonatal serum electrolyte and proteinuria screening on 46, XY ambiguous genitalia patients may allow early diagnosis of Denys‐Drash syndrome: a case report. Urology. 2021;153:312‐316. doi:10.1016/j.urology.2020.11.035

Özge K, Sezer A, Kadri Murat E, et al. Distinctively different phenotypes of two cases with a rare karyotype of 45, X/47, XYY mosaicism: case report and literature review. J Pediatr Res. 2022;9(4):401‐408.

Wei Z, Jiangfeng M, Xi W, et al. Case Report: Novel Compound Heterozygotic Variants in PPP2R3C Gene Causing Syndromic 46, XY Gonadal Dysgenesis and Literature Review. Frontiers in Genetics: Frontiers Media S.A; 2022.

Cheng Y, Xu C, Yang J, Zhou X, Chen N. Identification of a novel MAP3K1 variant in a family with 46, XY DSD and partial growth hormone deficiency. Mol Med Rep. 2022;26(5):338. doi:10.3892/mmr.2022.12854

Yu P‐H, Tsai M‐C, Chiang C‐T, Wang H‐Y, Kuo P‐L. Novel mutation of MAP3K1 gene in 46, XY DSD with complete gonadal dysgenesis. Taiwan J Obstet Gynecol. 2022;61(5):903‐905. doi:10.1016/j.tjog.2022.01.004

Rjiba K, Slimani W, Gaddas M, et al. Anomalies in human sex determination: usefulness of a combined cytogenetic approach to characterize an additional case with Xp functional disomy associated with 46, XY gonadal dysgenesis. J Clin Res Pediatr Endocrinol. 2023;15(1):25‐34. doi:10.4274/jcrpe.galenos.2022.2022‐3‐15

Nishi MY, Faria Júnior JAD, Krepischi ACV, et al. A small supernumerary Xp marker chromosome including genes NR0B1 and MAGEB causing partial gonadal dysgenesis and gonadoblastoma. Sex Dev. 2021;16(1):55‐63. doi:10.1159/000517085

Sharif S, Vakili S, Mobini M, et al. A novel variant luteinizing hormone receptor in the first transmembrane helix of two homozygous Iranian patients: case report. Egypt J Med Hum Genet. 2022;23(1):1‐7. doi:10.1186/s43042‐022‐00305‐w

Hong C, Peng L, Xin Y, Ruimin C. Two Novel Amhr2 Gene Variants in Monozygotic Twins with Persistent Müllerian Duct Syndrome: A Case Report and Functional Study. Wiley; 2022.

Nguyen TH, Nguyen DQ, Kim LNT, et al. Four novel mutations in the androgen receptor gene from Vietnamese patients with androgen insensitivity syndrome. Genes Genomics. 2023;45(4):467‐474. doi:10.1007/s13258‐022‐01249‐6

Aghaei S, Parvizpour S, Farrokhi E, Molavi N, Hoseinzadeh M, Tabatabaiefar MA. Characterization of a novel androgen receptor gene variant identified in an Iranian family with complete androgen insensitivity syndrome (CAIS): a molecular dynamics simulation study. J Biomol Struct Dyn. 2023;41(19):9850‐9864. doi:10.1080/07391102.2022.2148125

Çiftci N, Kayaş L, Çamtosun E, Akıncı A. 46, XY sex development defect due to a novel homozygous (splice site) c.673_1G>C variation in the HSD17B3 gene: case report. J Clin Res Pediatr Endocrinol. 2022;14(2):233‐238. doi:10.4274/jcrpe.galenos.2020.2020.0249

Gonçalves CI, Carriço J, Bastos M, Lemos MC. Disorder of sex development due to 17‐beta‐hydroxysteroid dehydrogenase type 3 deficiency: a case report and review of 70 different HSD17B3 mutations reported in 239 patients. Int J Mol Sci. 2022;23(17):10026. doi:10.3390/ijms231710026

Sreenivasan R, Bell K, van den Bergen J, et al. Whole exome sequencing reveals copy number variants in individuals with disorders of sex development. Mol Cell Endocrinol. 2022;546:111570. doi:10.1016/j.mce.2022.111570

Çelik N, Küçük Kurtulgan H, Kılıçbay F, et al. GATA‐4 variants in two unrelated cases with 46, XY disorder of sex development and review of the literature. J Clin Res Pediatr Endocrinol. 2022;14(4):469‐474. doi:10.4274/jcrpe.galenos.2021.2021.0112

Shichiri Y, Kato Y, Inagaki H, et al. A case of 46, XY disorders of sex development with congenital heart disease caused by a GATA4 variant. Congenit Anom (Kyoto). 2022;62(5):203‐207. doi:10.1111/cga.12482

Calonga‐Solís V, Fabbri‐Scallet H, Ott F, et al. MYRF: a new regulator of cardiac and early gonadal development‐insights from single cell rna sequencing analysis. J Clin Med. 2022;11(16):4858. doi:10.3390/jcm11164858

Xie C, Cai J, Li N, et al. Yolk sac tumor and dysgerminoma in the left gonad following gonadoblastoma in the right gonad in a 46, XY DSD with a novel SRY missense mutation: a case report. BMC Pregnancy Childbirth. 2023;23(1):1‐8. doi:10.1186/s12884‐022‐05317‐3

Harris KT, Pique DG, Wehrli LA, et al. Anorectal malformation in a 46, XY patient with a de novo stop‐loss variant in PPP1R12A and associated difference in sexual development: a case report. J Pediatr Surg Case Rep. 2023;95:102679. doi:10.1016/j.epsc.2023.102679

Chisato N, Noriyuki T, Manami S, et al. A case of 46, XY complete gonadal dysgenesis with a novel missense variant in SRY. Clin Pediatr Endocrinol. 2023;32(4):235‐238. doi:10.1297/cpe.2023‐0032

de Oliveira FR, Mazzola TN, de Mello MP, et al. DHX37 and NR5A1 variants identified in patients with 46, XY partial gonadal dysgenesis. Life. 2023;13(5):1093. doi:10.3390/life13051093

Meinel JA, Yumiceba V, Kuenstner A, et al. Disruption of the topologically associated domain at Xp21.2 is related to 46, XY gonadal dysgenesis. J Med Genet. 2023;60(5):469‐476. doi:10.1136/jmg‐2022‐108635

Noveski P, Plaseski T, Dimitrovska M, Plaseska‐Karanfilska D. Androgen insensitivity syndrome DUE to non‐coding variation in the androgen receptor gene: review of the literature and case report of a patient with mosaic c.‐547C>T variant. Balkan J Med Genet. 2023;26(1):51‐56. doi:10.2478/bjmg‐2023‐0012

Garcia A, Legendre M, Chantot‐Bastaraud S, Siffroi J‐P, Christin‐Maitre S. Unraveling a case of 46, XY DSD due to 17ß‐hydroxysteroid dehydrogenase type 3 mutations at the age of 49. Ann Endocrinol (Paris). 2023;84(2):260‐264. doi:10.1016/j.ando.2022.01.003

Rashmi KG, Ravichandran L, Roy A, et al. Clinical features of unrecognized congenital adrenal hyperplasia due to 17α‐hydroxylase deficiency since adolescence: a case report. J ASEAN Fed Endocr Soc. 2023;38(2):131‐134. doi:10.15605/jafes.038.02.08

Bergougnoux A, Gaspari L, Soleirol M, et al. Virilization at puberty in adolescent girls may reveal a 46, XY disorder of sexual development. Endocr Connect. 2023;12(12):e230267. doi:10.1530/ec‐23‐0267

Rahim Karim D, Mohamed Zahir A, Claahsen‐van der Grinten HL, Dineke W, Ben H. Novel likely pathogenic variant in NR5A1 gene in a Tanzanian child with 46, XY differences of sex development, inherited from the mosaic father. Endocrinol Diabetes Metab Case Rep. 2023;2023(2):22‐0384.

Yu Y, Lee PA, Huerta‐Saenz L, NG Allen. A novel variant in NR5A1 presenting as 46, XY difference of sex development. JCEM Case Rep. 2023;1(5):luad103. doi:10.1210/jcemcr/luad103

Correa Brito L, Grinspon RP, Lopez Dacal J, et al. Identification of a novel variant in myelin regulatory growth factor by next‐generation sequencing led to the detection of a clinically inapparent congenital heart defect in a patient with a 46, XY disorder of sex development. J Pers Med. 2023;13(7):1158. doi:10.3390/jpm13071158

Jian‐Wu S, Yi‐Wen Z, Yu‐Fei C, et al. Epididymis cell atlas in a patient with a sex development disorder and a novel NR5A1 gene mutation. Asian J Androl. 2023;25(1):103‐112.

Aversa T, Luppino G, Corica D, et al. A rare case of precocious puberty in a child with a novel GATA‐4 gene mutation: implications for disorders of sex development (DSD) and review of the literature. Genes. 2023;14(8):1631. doi:10.3390/genes14081631

Buonocore F, Clifford‐Mobley O, King TFJ, et al. Next‐generation sequencing reveals novel genetic variants (SRY, DMRT1, NR5A1, DHH, DHX37) in adults with 46, XY DSD. J Endocr Soc. 2019;3(12):2341‐2360. doi:10.1210/js.2019‐00306

Hughes LA, McKay‐Bounford K, Webb EA, et al. Next generation sequencing (NGS) to improve the diagnosis and management of patients with disorders of sex development (DSD). Endocr Connect. 2019;8(2):100‐110. doi:10.1530/EC‐18‐0376

Yu B‐Q, Liu Z‐X, Gao Y‐J, et al. Prevalence of gene mutations in a Chinese 46, XY disorders of sex development cohort detected by targeted next‐generation sequencing. Asian J Androl. 2021;23(1):69‐73.

Mazen I, Mekkawy M, Kamel A, et al. Advances in genomic diagnosis of a large cohort of Egyptian patients with disorders of sex development. Am J Med Genet A. 2021;185(6):1666‐1677. doi:10.1002/ajmg.a.62129

Ata A, Özen S, Onay H, et al. A large cohort of disorders of sex development and their genetic characteristics: 6 novel mutations in known genes. Eur J Med Genet. 2021;64(3):104154. doi:10.1016/j.ejmg.2021.104154

Miclea D, Alkhzouz C, Bucerzan S, et al. Molecular and cytogenetic analysis of romanian patients with differences in sex development. Diagnostics. 2021;11(11):2107. doi:10.3390/diagnostics11112107

Leitao Braga B, Lisboa Gomes N, Nishi MY, et al. Variants in 46, XY DSD‐related genes in syndromic and non‐syndromic small for gestational age children with hypospadias. Sex Dev. 2022;16(1):27‐33. doi:10.1159/000518091

Zidoune H, Ladjouze A, Chellat‐Rezgoune D, et al. Novel genomic variants, atypical phenotypes and evidence of a digenic/oligogenic contribution to disorders/differences of sex development in a large North African Cohort. Front Genet. 2022;13:90574. doi:10.3389/fgene.2022.900574

Gomes NL, Batista RL, Nishi MY, et al. Contribution of clinical and genetic approaches for diagnosing 209 index cases with 46, XY differences of sex development. J Clin Endocrinol Metab. 2022;107(5):e1797‐e1806. doi:10.1210/clinem/dgac064

Globa E, Zelinska N, Shcherbak Y, Bignon‐Topalovic J, Bashamboo A, MсElreavey K. Disorders of sex development in a large Ukrainian Cohort: clinical diversity and genetic findings. Front Endocrinol (Lausanne). 2022;13:810782. doi:10.3389/fendo.2022.810782

Tang Y, Chen Y, Wang J, et al. Clinical characteristics and genetic expansion of 46, XY disorders of sex development children in a Chinese prospective study. Endocr Connect. 2023;12(10):e230029. doi:10.1530/ec‐23‐0029

The Principles of Clinical Cytogenetics. Gersen SL, Keagle MB, eds. Humana Press; 1999.

Mekkawy M, Kamel A, El‐Ruby M, et al. Isodicentric Y chromosomes in Egyptian patients with disorders of sex development (DSD). Am J Med Genet A. 2012;158A(7):1594‐1603. doi:10.1002/ajmg.a.35487

Robinson DO, Dalton P, Jacobs PA, et al. A molecular and FISH analysis of structurally abnormal Y chromosomes in patients with Turner syndrome. J Med Genet. 1999;36(4):279‐284.

de la Paz‐Gallardo MJ, García FSM, de Haro‐Muñoz TD, et al. Quantitative‐fluorescent‐PCR versus full karyotyping in prenatal diagnosis of common chromosome aneuploidies in southern Spain. Clin Chem Lab Med. 2015;53(9):1333‐1338. doi:10.1515/cclm‐2014‐0781

Allingham‐Hawkins DJ, Chitayat D, Cirigliano V, et al. Prospective validation of quantitative fluorescent polymerase chain reaction for rapid detection of common aneuploidies. Genet Med. 2011;13(2):140‐147. doi:10.1097/GIM.0b013e3182036763

White S, Ohnesorg T, Notini A, et al. Copy number variation in patients with disorders of sex development due to 46, XY gonadal dysgenesis. PLoS ONE. 2011;6(3):e17793. doi:10.1371/journal.pone.0017793

Schouten J, van Vught P, Galjaard RJ. Multiplex ligation‐dependent probe amplification (MLPA) for prenatal diagnosis of common aneuploidies. Methods Mol Biol. 2019;1885:161‐170. doi:10.1007/978‐1‐4939‐8889‐1_11

Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation‐dependent probe amplification. Nucleic Acids Res. 2002;30(12):e57. doi:10.1093/nar/gnf056

Bashamboo A, Ledig S, Wieacker P, Achermann JC, McElreavey K. New technologies for the identification of novel genetic markers of disorders of sex development (DSD). Sex Dev. 2010;4(4‐5):213‐224. doi:10.1159/000314917

Croft B, Ayers K, Sinclair A, Ohnesorg T. Review disorders of sex development: the evolving role of genomics in diagnosis and gene discovery. Birth Defects Res C Embryo Today. 2016;108(4):337‐350. doi:10.1002/bdrc.21148

Evangelidou P, Alexandrou A, Moutafi M, et al. Implementation of high resolution whole genome array CGH in the prenatal clinical setting: advantages, challenges, and review of the literature. Biomed Res Int. 2013;2013:346762‐346762. doi:10.1155/2013/346762

Kon M, Fukami M. Submicroscopic copy‐number variations associated with 46, XY disorders of sex development. Mol Cell Pediatr. 2015;2(1):7. doi:10.1186/s40348‐015‐0018‐2

Croft B, Ohnesorg T, Sinclair AH. The role of copy number variants in disorders of sex development. Sex Dev. 2018;12(1‐3):19‐29. doi:10.1159/000481896

León NY, Reyes AP, Harley VR. A clinical algorithm to diagnose differences of sex development. Lancet Diabetes Endocrinol. 2019;7(7):560‐574. doi:10.1016/s2213‐8587(18)30339‐5

O'Connell MA, Atlas G, Ayers K, Sinclair A. Establishing a molecular genetic diagnosis in children with differences of sex development: a clinical approach. Horm Res Paediatr. 2023;96(2):128‐143. doi:10.1159/000520926

Alhomaidah D, McGowan R, Ahmed SF. The current state of diagnostic genetics for conditions affecting sex development. Clin Genet. 2017;91(2):157‐162. doi:10.1111/cge.12912

De Cario R, Kura A, Suraci S, et al. Sanger validation of high‐throughput sequencing in genetic diagnosis: still the best practice? Front Genet. 2020;11:592588. doi:10.3389/fgene.2020.592588

Zhong Y, Xu F, Wu J, Schubert J, Li MM. Application of next generation sequencing in laboratory medicine. Ann Lab Med. 2021;41(1):25‐43. doi:10.3343/alm.2021.41.1.25

Rothberg JM, Hinz W, Rearick TM, et al. An integrated semiconductor device enabling non‐optical genome sequencing. Nature. 2011;475(7356):348‐352. doi:10.1038/nature10242

Arboleda VA, Lee H, Sánchez FJ, et al. Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development. Clin Genet. 2013;83:35‐43.

Laurie S, Fernandez‐Callejo M, Marco‐Sola S, et al. From wet‐lab to variations: concordance and speed of bioinformatics pipelines for whole genome and whole exome sequencing. Hum Mutat. 2016;37(12):1263‐1271. doi:10.1002/humu.23114

LaDuca H, Farwell KD, Vuong H, et al. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels. PLoS ONE. 2017;12(2):e0170843. doi:10.1371/journal.pone.0170843

Zhang D, Wang D, Tong Y, et al. A novel c.64G > T (p.G22C) NR5A1 variant in a Chinese adolescent with 46, XY disorders of sex development: a case report. BMC Pediatrics. 2023;23(1):182. doi:10.1186/s12887‐023‐03974‐7

Ayers KL, Eggers S, Rollo BN, et al. Variants in SART3 cause a spliceosomopathy characterised by failure of testis development and neuronal defects. Nat Commun. 2023;14(1):3403. doi:10.1038/s41467‐023‐39040‐0

da Silva TE, Gomes NL, Lerário AM, et al. Genetic evidence of the association of DEAH‐box helicase 37 defects with 46, XY gonadal dysgenesis spectrum. J Clin Endocrinol Metab. 2019;104(12):5923‐5934. doi:10.1210/jc.2019‐00984

Harris A, Siggers P, Corrochano S, et al. ZNRF3 functions in mammalian sex determination by inhibiting canonical WNT signaling. Proc Natl Acad Sci USA. 2018;115(21):5474‐5479. doi:10.1073/pnas.1801223115

Zhang W, Mao J, Wang X, et al. Case report: novel compound heterozygotic variants in PPP2R3C gene causing syndromic 46, XY gonadal dysgenesis and literature review. Front Genet. 2022;13:871328. doi:10.3389/fgene.2022.871328

Cicek D, Warr N, Yesil G, et al. Broad‐spectrum XX and XY gonadal dysgenesis in patients with a homozygous L193S variant in PPP2R3C. Eur J Endocrinol. 2021;186(1):65‐72. doi:10.1530/eje‐21‐0910

Kouri C, Sommer G, Martinez de Lapiscina I, et al. Clinical and genetic characteristics of a large international cohort of individuals with rare NR5A1/SF‐1 variants of sex development. eBioMedicine. 2024;99:104941. doi:10.1016/j.ebiom.2023.104941

Leitao Braga B, Lisboa Gomes N, Nishi MY, et al. Variants in 46, XY DSD‐related genes in syndromic and non‐syndromic small for gestational age children with hypospadias. Sex Dev. 2022;16:27.

Atlas G, Sreenivasan R, Sinclair A. Targeting the non‐coding genome for the diagnosis of disorders of sex development. Sex Dev. 2021;15(5‐6):392‐410. doi:10.1159/000519238

Çiftci N, Kayaş L, Çamtosun E, Akıncı A. 46, XY sex development defect due to a novel homozygous (splice site) c.673_1G>C variation in the HSD17B3 gene: case report. J Clin Res Pediatr Endocrinol. 2022;14(2):233‐238. doi:10.4274/jcrpe.galenos.2020.2020.0249

Känsäkoski J, Jääskeläinen J, Jääskeläinen T, et al. Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon‐activating mutation in the androgen receptor gene. Sci Rep. 2016;6:32819‐32819. doi:10.1038/srep32819

Ohnesorg T, Croft B, Tan J, Sinclair AH. Using ROADMAP data to identify enhancers associated with disorders of sex development. Sex Dev. 2016;10(2):59‐65. doi:10.1159/000445398

Belkadi A, Bolze A, Itan Y, et al. Whole‐genome sequencing is more powerful than whole‐exome sequencing for detecting exome variants. Proc Natl Acad Sci USA. 2015;112(17):5473‐5478. doi:10.1073/pnas.1418631112

Alkhunaizi E, Chitayat D. PPP1R12A‐related urogenital and/or brain malformation syndrome. In: Adam MP, Feldman J, Mirzaa GM, eds. GeneReviews(®).University of Washington; 1993.

Ito M, Nakano T, Erdodi F, Hartshorne DJ. Myosin phosphatase: structure, regulation and function. Mol Cell Biochem. 2004;259(1‐2):197‐209. doi:10.1023/b:mcbi.0000021373.14288.00

Egbert JR, Silbern I, Uliasz TF, et al. Phosphatases modified by LH signaling in ovarian follicles: testing their role in regulating the NPR2 guanylyl cyclase†. Biol Reprod. 2024;110(1):102‐115. doi:10.1093/biolre/ioad130

Saez JM. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr Rev. 1994;15(5):574‐626. doi:10.1210/edrv‐15‐5‐574

Meinel JA, Yumiceba V, Künstner A, et al. Disruption of the topologically associated domain at Xp21.2 is related to 46, XY gonadal dysgenesis. J Med Genet. 2023;60(5):469‐476. doi:10.1136/jmg‐2022‐108635

Krumm N, Hoffman N. Practical estimation of cloud storage costs for clinical genomic data. Pract Lab Med. 2020;21:e00168. doi:10.1016/j.plabm.2020.e00168

Krude H, Mundlos S, Øien NC, Opitz R, Schuelke M. What can go wrong in the non‐coding genome and how to interpret whole genome sequencing data. Med Genet. 2021;33(2):121‐131. doi:10.1515/medgen‐2021‐2071. Medizinische Genetik.

Schwarz JM, Lüpken R, Seelow D, Kehr B. Novel sequencing technologies and bioinformatic tools for deciphering the non‐coding genome. Med Gen. 2021;33(2):133‐145. doi:10.1515/medgen‐2021‐2072

Kim JH, Kang E, Heo SH, et al. Diagnostic yield of targeted gene panel sequencing to identify the genetic etiology of disorders of sex development. Mol Cell Endocrinol. 2017;444:19‐25. doi:10.1016/j.mce.2017.01.037

Krijger PH, de Laat W. Regulation of disease‐associated gene expression in the 3D genome. Nat Rev Mol Cell Biol. 2016;17(12):771‐782. doi:10.1038/nrm.2016.138

Lieberman‐Aiden E, van Berkum NL, Williams L, et al. Comprehensive mapping of long‐range interactions reveals folding principles of the human genome. Science. 2009;326(5950):289‐293. doi:10.1126/science.1181369

Melo US, Schöpflin R, Acuna‐Hidalgo R, et al. Hi‐C identifies complex genomic rearrangements and TAD‐shuffling in developmental diseases. Am J Hum Genet. 2020;106(6):872‐884. doi:10.1016/j.ajhg.2020.04.016

Croft B, Ohnesorg T, Hewitt J, et al. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9. Nat Commun. 2018;9(1):5319. doi:10.1038/s41467‐018‐07784‐9

Gonen N, Futtner CR, Wood S, et al. Sex reversal following deletion of a single distal enhancer of Sox9. Science. 2018;360(6396):1469‐1473. doi:10.1126/science.aas9408

Smyk M, Akdemir KC, Stankiewicz P. SOX9 chromatin folding domains correlate with its real and putative distant cis‐regulatory elements. Nucleus. 2017;8(2):182‐187. doi:10.1080/19491034.2017.1279776

Guo X, Ohler U, Yildirim F. How to find genomic regions relevant for gene regulation. Med Gen. 2021;33(2):157‐165. doi:10.1515/medgen‐2021‐2074

Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405‐424. doi:10.1038/gim.2015.30

Zidoune H, Ladjouze A, Chellat‐Rezgoune D, et al. Novel genomic variants, atypical phenotypes and evidence of a digenic/oligogenic contribution to disorders/differences of sex development in a large North African Cohort. Front Genet. 2022;13:900574. doi:10.3389/fgene.2022.900574

Petrovski S, Goldstein DB. Unequal representation of genetic variation across ancestry groups creates healthcare inequality in the application of precision medicine. Genome Biol. 2016;17(1):157. doi:10.1186/s13059‐016‐1016‐y

Del Gobbo GF, Wang X, Couse M, et al. Long‐read genome sequencing reveals a novel intronic retroelement insertion in NR5A1 associated with 46, XY differences of sexual development. Am J Hum Genet A. 2024;194(5):e63522. doi:10.1002/ajmg.a.63522

Molendijk J, Parker BL. Proteome‐wide systems genetics to identify functional regulators of complex traits. Cell Syst. 2021;12(1):5‐22. doi:10.1016/j.cels.2020.10.005

Tucker EJ, Baker MJ, Hock DH, et al. Premature ovarian insufficiency in CLPB deficiency: transcriptomic, proteomic and phenotypic insights. J Clin Endocrinol Metab. 2022;107(12):3328‐3340. doi:10.1210/clinem/dgac528

Terkelsen T, Mikkelsen NS, Bak EN, et al. CRISPR activation to characterize splice‐altering variants in easily accessible cells. Am J Hum Genet. 2024;111(2):309‐322. doi:10.1016/j.ajhg.2023.12.024

Lundgaard Riis M, Jørgensen A. Deciphering sex‐specific differentiation of human fetal gonads: insight from experimental models. Front Cell Dev Biol. 2022;10:902082. doi:10.3389/fcell.2022.902082

Li L, Dong J, Yan L, et al. Single‐Cell RNA‐Seq Analysis Maps Development of Human Germline Cells and Gonadal Niche Interactions. Cell Stem Cell. 2017;20(6):858‐873.e4. doi:10.1016/j.stem.2017.03.007

Taelman J, Czukiewska SM, Moustakas I, et al. Characterization of the human fetal gonad and reproductive tract by single‐cell transcriptomics. Dev Cell. 2024;59(4):529‐544.e5. doi:10.1016/j.devcel.2024.01.006

Garcia‐Alonso L, Lorenzi V, Mazzeo CI, et al. Single‐cell roadmap of human gonadal development. Nature. 2022;607(7919):540‐547. doi:10.1038/s41586‐022‐04918‐4

Hamanaka K, Takata A, Uchiyama Y, et al. MYRF haploinsufficiency causes 46, XY and 46, XX disorders of sex development: bioinformatics consideration. Hum Mol Genet. 2019;28(14):2319‐2329. doi:10.1093/hmg/ddz066

Rodríguez Gutiérrez D, Biason‐Lauber A. Pluripotent cell models for gonadal research. Int J Mol Sci. 2019;20(21):5495. doi:10.3390/ijms20215495

Mohiuddin M, Kooy RF, Pearson CE. De novo mutations, genetic mosaicism and human disease. Front Genet. 2022;13:983668. doi:10.3389/fgene.2022.983668

Rydzanicz M, Olszewski P, Kedra D, et al. Variable degree of mosaicism for tetrasomy 18p in phenotypically discordant monozygotic twins‐diagnostic implications. Mol Genet Genomic Med. 2021;9(1):e1526. doi:10.1002/mgg3.1526

Francis DI, Stark Z, Scheffer IE, et al. Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability. Eur J Hum Genet. 2023;31(5):521‐525. doi:10.1038/s41431‐022‐01232‐5

King DA, Sifrim A, Fitzgerald TW, et al. Detection of structural mosaicism from targeted and whole‐genome sequencing data. Genome Res. 2017;27(10):1704‐1714. doi:10.1101/gr.212373.116

Wilhelm D, Washburn LL, Truong V, Fellous M, Eicher EM, Koopman P. Antagonism of the testis‐ and ovary‐determining pathways during ovotestis development in mice. Mech Dev. 2009;126(5‐6):324‐336. doi:10.1016/j.mod.2009.02.006

Chen YS, Racca JD, Weiss MA. Tenuous transcriptional threshold of human sex determination. I. SRY and Swyer syndrome at the edge of ambiguity. Front Endocrinol (Lausanne). 2022;13:945030. doi:10.3389/fendo.2022.945030

Bhagavath B, Layman LC, Ullmann R, et al. Familial 46, XY sex reversal without campomelic dysplasia caused by a deletion upstream of the SOX9 gene. Mol Cell Endocrinol. 2014;393(1‐2):1‐7. doi:10.1016/j.mce.2014.05.006

Kim GJ, Sock E, Buchberger A, et al. Copy number variation of two separate regulatory regions upstream of SOX9 causes isolated 46, XY or 46, XX disorder of sex development. J Med Genet. 2015;52(4):240‐247. doi:10.1136/jmedgenet‐2014‐102864

Benko S, Gordon CT, Mallet D, et al. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. J Med Genet. 2011;48(12):825‐830. doi:10.1136/jmedgenet‐2011‐100255

Tantawy S, Mazen I, Soliman H, et al. Analysis of the gene coding for steroidogenic factor 1 (SF1, NR5A1) in a cohort of 50 Egyptian patients with 46, XY disorders of sex development. Eur J Endocrinol. 2014;170(5):759‐767. doi:10.1530/eje‐13‐0965

Mendonca BB, Gomes NL, Costa EM, et al. XY disorder of sex development (DSD) due to 17β‐hydroxysteroid dehydrogenase type 3 deficiency. J Steroid Biochem Mol Biol. 2017;46(pt A):79‐85. doi:10.1016/j.jsbmb.2016.05.002

Kon M, Suzuki E, Dung VC, et al. Molecular basis of non‐syndromic hypospadias: systematic mutation screening and genome‐wide copy‐number analysis of 62 patients. Hum Reprod. 2015;30(3):499‐506. doi:10.1093/humrep/deu364

Kouri C, Sommer G, Flück CE. Oligogenic causes of human differences of sex development: facing the challenge of genetic complexity. Horm Res Paediatr. 2023;96(2):169‐179. doi:10.1159/000519691

Warburton PE, Sebra RP. Long‐read DNA sequencing: recent advances and remaining challenges. Annu Rev Genomics Hum Genet. 2023;24:109‐132. doi:10.1146/annurev‐genom‐101722‐103045

Rhoads A, Au KF. PacBio sequencing and its applications. Genom Proteom Bioinf. 2015;13(5):278‐289. doi:10.1016/j.gpb.2015.08.002

Bowden R, Davies RW, Heger A, et al. Sequencing of human genomes with nanopore technology. Nat Commun. 2019;10(1):1869. doi:10.1038/s41467‐019‐09637‐5

Oehler JB, Wright H, Stark Z, Mallett AJ, Schmitz U. The application of long‐read sequencing in clinical settings. Hum Genomics. 2023;17(1):73. doi:10.1186/s40246‐023‐00522‐3

Nurk S, Koren S, Rhie A, et al. The complete sequence of a human genome. Science. 2022;376(6588):44‐53. doi:10.1126/science.abj6987

Kalle E, Kubista M, Rensing C. Multi‐template polymerase chain reaction. Biomol Detect Quantif. 2014;2:11‐29. doi:10.1016/j.bdq.2014.11.002

Zhang X, Liu CG, Yang SH, Wang X, Bai FW, Wang Z. Benchmarking of long‐read sequencing, assemblers and polishers for yeast genome. Brief Bioinform. 2022;23(3):bbac146. doi:10.1093/bib/bbac146

Stevanovski I, Chintalaphani SR, Gamaarachchi H, et al. Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. Sci Adv. 2022;8(9):eabm5386. doi:10.1126/sciadv.abm5386

Dias R, Torkamani A. Artificial intelligence in clinical and genomic diagnostics. Genome Medicine. 2019;11(1):70. doi:10.1186/s13073‐019‐0689‐8

Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535‐548.e24. doi:10.1016/j.cell.2018.12.015

Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310‐315. doi:10.1038/ng.2892

Cheng J, Novati G, Pan J, et al. Accurate proteome‐wide missense variant effect prediction with AlphaMissense. Science;381(6664):eadg7492. doi:10.1126/science.adg7492

Hsieh T‐C, Mensah MA, Pantel JT, et al. PEDIA: prioritization of exome data by image analysis. Genet Med. 2019;21(12):2807‐2814. doi:10.1038/s41436‐019‐0566‐2

Ning D, Zhang Z, Qiu K, et al. Efficacy of intelligent diagnosis with a dynamic uncertain causality graph model for rare disorders of sex development. Front Med. 2020;14(4):498‐505. doi:10.1007/s11684‐020‐0791‐8

Genomic technologies and the diagnosis of 46, XY differences of sex development.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Subventions

Informations de copyright

Références

Auteurs

Firman Idris (F)

Andrew H Sinclair (AH)

Katie L Ayers (KL)

Classifications MeSH